Log in to search using one of your social media accounts:

 

FTC Sending Refund Checks Totaling More Than $210,000 to Consumers Who Bought Elimidrol ‘Opiate Withdrawal’ Product

The Federal Trade Commission is mailing 5,379 refund checks totaling more than $210,000 to people who bought Elimidrol, a product marketed by Sunrise Nutraceuticals, LLC, as an effective treatment for opiate addiction withdrawal. The average refund amount is  $39.
Source: NCCAM Featured Content - Category: Complementary Medicine Authors: Source Type: news

Related Links:

Between April, 2016 and March 31, 2017, the Canadian Institute for Health Information (CIHI) identified 1,846 babies admitted to hospital after being exposed to opioids during pregnancy.
Source: CBC | Health - Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news
26 –29 October 2017, Abu Dhabi, United Arab Emirates
Source: Scientific and Medical Events on Global Events List - Category: Science Source Type: events
Publication date: 2017 Source:International Review of Neurobiology, Volume 136 Author(s): Todd E. Thiele Neuropeptides are short sequences of amino acids that are coexpressed with neurotransmitters and which are widely expressed throughout the central nervous system. There is a large database of data pointing to critical roles for neuropeptides in modulating neurobiological responses to alcohol and drugs of abuse. Continued alcohol and drug use promote allostatic alterations in neuropeptide systems, and these changes contribute to excessive and uncontrolled intake that emerges with dependence. The neuropeptides that are r...
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research
Publication date: 2017 Source:International Review of Neurobiology, Volume 136 Author(s): Marisa Roberto, Samantha R. Spierling, Dean Kirson, Eric P. Zorrilla Drug addiction is a complex disorder that is characterized by compulsivity to seek and take the drug, loss of control in limiting intake of the drug, and emergence of a withdrawal syndrome in the absence of the drug. The transition from casual drug use to dependence is mediated by changes in reward and brain stress functions and has been linked to a shift from positive reinforcement to negative reinforcement. The recruitment of brain stress systems mediates the nega...
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research
Publication date: 2017 Source:International Review of Neurobiology, Volume 136 Author(s): Anushree Karkhanis, Katherine M. Holleran, Sara R. Jones The dynorphin/kappa opioid receptor (KOR) system is implicated in the “dark side” of addiction, in which stress exacerbates maladaptive responses to drug and alcohol exposure. For example, acute stress and acute ethanol exposure result in an elevation in dynorphin, the KOR endogenous ligand. Activation of KORs results in modulation of several neurotransmitters; however, this chapter will focus on its regulatory effects on dopamine in mesolimbic areas. Specifically, ...
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research
Publication date: 2017 Source:International Review of Neurobiology, Volume 136 Author(s): Lia J. Zallar, Mehdi Farokhnia, Brendan J. Tunstall, Leandro F. Vendruscolo, Lorenzo Leggio In the past years, a significant volume of research has implicated the appetitive hormone ghrelin in the mechanisms underlying drug use and addiction. From a neuroscientific standpoint, ghrelin modulates both reward and stress pathways, two key drivers of substance use behaviors. Previous investigations support a connection between the ghrelin system and alcohol, stimulants, and tobacco use in both animals and humans, while the research on opi...
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research
Publication date: 2017 Source:International Review of Neurobiology, Volume 136 Author(s): Jesse R. Schank, Markus Heilig Substance P (SP) is an 11-amino acid neuropeptide of the tachykinin family that preferentially activates the neurokinin-1 receptor (NK1R). First isolated 85 years ago and sequenced 40 years later, SP has been extensively studied. Early studies identified a role for SP and the NK1R in contraction of intestinal smooth muscle, central pain processing, and neurogenic inflammation. An FDA-approved NK1R antagonist, aprepitant, is used clinically for the treatment of chemotherapy-induced nausea, as the NK1R in...
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research
Publication date: 2017 Source:International Review of Neurobiology, Volume 136 Author(s): Cort A. Pedersen Substance use disorders blight the lives of millions of people and inflict a heavy financial burden on society. There is a compelling need for new pharmacological treatments as current drugs have limited efficacy and other major drawbacks. A substantial number of animal and recent clinical studies indicate that the neuropeptide, oxytocin, is a particularly promising therapeutic agent for human addictions, especially alcohol use disorders. In preliminary trials, we found that oxytocin administered by the intranasal ro...
Source: International Review of Neurobiology - Category: Neuroscience Source Type: research
Depression and worries about appearance common in those who can't skip the tanning bed, study finds
Source: Cancercompass News: Other Cancer - Category: Cancer & Oncology Source Type: news
Certain behaviors are a dead giveaway for spotting a drug addict in the workplace
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news
More News: Addiction | Complementary Medicine